Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA issues warnings for illegally selling supplements | Telehealth for CVD | OAC use among older AFib patients
Monday, November 21, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA warns 7 companies for illegally selling dietary supplements that claim to treat CVD

The companies were given 15 days to provide an adequate response to the FDA's warning. The agency said its next step could include legal action. 

READ MORE >
Based on this evidence, its is recommended using monotherapy with ticagrelor or prasugrel after one to three months of DAPT after PCI for acute coronary syndrome (ACS), but not using monotherapy of aspirin or clopidogrel unless the patient has a high bleeding risk.
Share on Twitter Share on Facebook Share on Linkedin

FDA warns 7 companies for illegally selling dietary supplements that claim to treat CVD

Share on Twitter Share on Facebook Share on Linkedin
Based on this evidence, its is recommended using monotherapy with ticagrelor or prasugrel after one to three months of DAPT after PCI for acute coronary syndrome (ACS), but not using monotherapy of aspirin or clopidogrel unless the patient has a high bleeding risk.
The companies were given 15 days to provide an adequate response to the FDA's warning. The agency said its next step could include legal action. 
READ MORE >

Telehealth for cardiovascular disease patients: 3 key benefits and 5 ongoing challenges

Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 

READ MORE >
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
Share on Twitter Share on Facebook Share on Linkedin

Telehealth for cardiovascular disease patients: 3 key benefits and 5 ongoing challenges

Share on Twitter Share on Facebook Share on Linkedin
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
READ MORE >

OAC use among older AFib patients is on the rise

However, researchers noted, there is still considerable room for improvement.

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

OAC use among older AFib patients is on the rise

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
However, researchers noted, there is still considerable room for improvement.
READ MORE >

Featured Articles

Elon Musk and Eli Lilly: How a fake tweet caused chaos and reignited the debate over insulin prices

Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 

READ MORE >
Smartphone mHealth. Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 
Share on Twitter Share on Facebook Share on Linkedin

Elon Musk and Eli Lilly: How a fake tweet caused chaos and reignited the debate over insulin prices

Share on Twitter Share on Facebook Share on Linkedin
Smartphone mHealth. Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 
Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 
READ MORE >

VIDEO: High sensitivity cardiac troponin use based on the NCDR Chest Pain-MI Registry 

Cian McCarthy, MD, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin.

READ MORE >
Cian McCarthy, MD, cardiovascular fellow, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin. However, he expects that to rise because of high sensitivity troponin (hs-cTn) being included in recent guidelines as a front-line test.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: High sensitivity cardiac troponin use based on the NCDR Chest Pain-MI Registry 

Share on Twitter Share on Facebook Share on Linkedin
Cian McCarthy, MD, cardiovascular fellow, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin. However, he expects that to rise because of high sensitivity troponin (hs-cTn) being included in recent guidelines as a front-line test.
Cian McCarthy, MD, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin.
READ MORE >

Tracking the health benefits of influenza vaccines: ‘If you have heart failure, you should get your flu shot’

The new analysis focused on data from more than 5,000 heart failure patients throughout Asia, the Middle East and Africa.

READ MORE >
Flu Shots can help lower risk factors to prevent cardiac events in a new study. Flu shots are associated with a significant reduction in the risk of cardiovascular complications or pneumonia in patients with heart failure, according to new findings published in The Lancet Global Health.
Share on Twitter Share on Facebook Share on Linkedin

Tracking the health benefits of influenza vaccines: ‘If you have heart failure, you should get your flu shot’

Share on Twitter Share on Facebook Share on Linkedin
Flu Shots can help lower risk factors to prevent cardiac events in a new study. Flu shots are associated with a significant reduction in the risk of cardiovascular complications or pneumonia in patients with heart failure, according to new findings published in The Lancet Global Health.
The new analysis focused on data from more than 5,000 heart failure patients throughout Asia, the Middle East and Africa.
READ MORE >

In Case You Missed It

Fish oil, garlic and other ‘heart-healthy’ dietary supplements do not improve cholesterol levels

The new analysis was presented at the AHA Scientific Sessions 2022 conference and simultaneously published in the Journal of the American College of Cardiology.

READ MORE >
Fish oil supplements are used to reduce cardiovascular disease risk, but can actually increase the risk of atrial fibrillation in some patients.
Share on Twitter Share on Facebook Share on Linkedin

Fish oil, garlic and other ‘heart-healthy’ dietary supplements do not improve cholesterol levels

Share on Twitter Share on Facebook Share on Linkedin
Fish oil supplements are used to reduce cardiovascular disease risk, but can actually increase the risk of atrial fibrillation in some patients.
The new analysis was presented at the AHA Scientific Sessions 2022 conference and simultaneously published in the Journal of the American College of Cardiology.
READ MORE >

AI-powered CCTA outperforms usual care when evaluating stable chest pain

The new study, presented at the AHA Scientific Sessions 2022 conference in Chicago, focused on data from more than 2,000 patients. 

READ MORE >
HeartFlow FFR-CT
Share on Twitter Share on Facebook Share on Linkedin

AI-powered CCTA outperforms usual care when evaluating stable chest pain

Share on Twitter Share on Facebook Share on Linkedin
HeartFlow FFR-CT
The new study, presented at the AHA Scientific Sessions 2022 conference in Chicago, focused on data from more than 2,000 patients. 
READ MORE >

In Other News

Kaiser avoids historic nursing strike by boosting pay 22.5%

Kaiser Permanente staved off what would have been the largest private-sector nursing strike after reaching an agreement with 21,000 unionized Northern California nurses.

READ MORE >
nursing_best_practices.png
Share on Twitter Share on Facebook Share on Linkedin

Kaiser avoids historic nursing strike by boosting pay 22.5%

Share on Twitter Share on Facebook Share on Linkedin
nursing_best_practices.png
Kaiser Permanente staved off what would have been the largest private-sector nursing strike after reaching an agreement with 21,000 unionized Northern California nurses.
READ MORE >

Falsified timesheets get radiologist suspended years after the fact

A U.K. radiologist has received a six-month suspension for taking pay on unworked hours back in 2012 and 2013.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Falsified timesheets get radiologist suspended years after the fact

Share on Twitter Share on Facebook Share on Linkedin
A U.K. radiologist has received a six-month suspension for taking pay on unworked hours back in 2012 and 2013.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme